FDA s George Mills on Digital Imaging s Future in the Agency | GenomeWeb

To understand the role that George Mills plays in how medical imaging will be used as a drug approval tool by the FDA, look at the agenda for the Drug Information Association meeting on imaging to be held in Betheda, Md., May 5-6. Mills is giving a keynote presentation and leading two other sessions of the workshop.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.